ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
5 hedge funds and large institutions have $539K invested in ENVUE MEDICAL INC NEW in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
67% more funds holding
Funds holding: 3 → 5 (+2)
3.19% more ownership
Funds ownership: 14.72% → 17.91% (+3.2%)
62% less capital invested
Capital invested by funds: $1.43M → $539K (-$889K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$160K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$63.9K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$32K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$243K |
FEED Hedge Fund Activity: Q3 2020 in Review
5 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q3 2020, worth a combined $539K — down 62% from $1.43M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FEED positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Kennedy Capital Management, adding an estimated $160K. The largest seller was Worth Venture Partners, exiting entirely with an estimated $243K sold.
- 5 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q3 2020, up from 3 in Q2 2020.
- Funds reported $539K of ENVUE MEDICAL INC NEW stock for Q3 2020, down 62% quarter-over-quarter.
- 3 funds opened new ENVUE MEDICAL INC NEW positions in Q3 2020 and 1 closed out, a net change of +2 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q3 2020 was Kennedy Capital Management, an estimated $160K added.
- The largest ENVUE MEDICAL INC NEW seller in Q3 2020 was Worth Venture Partners, an estimated $243K sold.
Based on aggregated 13F filings for Q3 2020.